Skip to content

Author

Zihnil A. I. Mazrad

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Dual-targeting poly(2-oxazoline)-coated porous silicon nanoparticles for improving osteosarcoma therapy.

Osteosarcoma is the most prevalent malignant bone tumor in children and adolescents. Current treatment of this aggressive tumor with surgery and chemotherapy is hindered by the non-selectivity of chemotherapeutics, leading to severe toxicity and poor outcomes. This urgent clinical challenge necessitates the need for ta...

Mona A. Abdelmoneem, Lars Esser, Zihnil A. I. Mazrad et al. · 0 citations
Review Open access Aug 2026

Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations

Overall, PEG lipid alternatives should not be viewed as simple PEG mimics, but as distinct surface‐engineering materials that create new nano‐bio interfaces and reshape LNP behavior in biological systems.

Zihnil A. I. Mazrad, Yi Ju, S. J. Kent et al. · 3 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.